137 related articles for article (PubMed ID: 21937260)
1. Radiation-associated head and neck sarcomas: spectrum of imaging findings.
Debnam JM; Guha-Thakurta N; Mahfouz YM; Garden AS; Benjamin RS; Sturgis EM; Ginsberg LE
Oral Oncol; 2012 Feb; 48(2):155-61. PubMed ID: 21937260
[TBL] [Abstract][Full Text] [Related]
2. CT and MRI of radiation-induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma.
Cai PQ; Wu YP; Li L; Zhang R; Xie CM; Wu PH; Xu JH
Clin Radiol; 2013 Jul; 68(7):683-9. PubMed ID: 23477476
[TBL] [Abstract][Full Text] [Related]
3. Imaging findings of radiation-induced sarcoma of the head and neck.
Makimoto Y; Yamamoto S; Takano H; Motoori K; Ueda T; Kazama T; Kaneoya K; Shimofusa R; Uno T; Ito H; Hanazawa T; Okamoto Y; Hayasaki K
Br J Radiol; 2007 Oct; 80(958):790-7. PubMed ID: 17908819
[TBL] [Abstract][Full Text] [Related]
4. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
[TBL] [Abstract][Full Text] [Related]
5. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.
Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH
Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627
[TBL] [Abstract][Full Text] [Related]
6. Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.
Partovi S; Kohan A; Vercher-Conejero JL; Rubbert C; Margevicius S; Schluchter MD; Gaeta C; Faulhaber P; Robbin MR
AJNR Am J Neuroradiol; 2014 Oct; 35(10):1970-5. PubMed ID: 24924545
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and prognostic factors of post-irradiation and de novo sarcomas of the head and neck: a histologically matched case-control study.
Yeang MS; Tay K; Ong WS; Thiagarajan A; Tan DS; Ha TC; Teo PT; Soo KC; Tan HK; Iyer NG
Ann Surg Oncol; 2013 Sep; 20(9):3066-75. PubMed ID: 23604715
[TBL] [Abstract][Full Text] [Related]
8. CT, MRI, and
Kim HY; Hwang JY; Kim HJ; Kim YK; Cha J; Park GM; Kim ST
Acta Radiol; 2017 Oct; 58(10):1222-1230. PubMed ID: 28068826
[TBL] [Abstract][Full Text] [Related]
9. Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases.
Sheppard DG; Libshitz HI
Clin Radiol; 2001 Jan; 56(1):22-9. PubMed ID: 11162693
[TBL] [Abstract][Full Text] [Related]
10. ¹⁸F-fluorodeoxyglucose-positron emission tomography/computed tomography in malignancies of the thyroid and in head and neck squamous cell carcinoma: a review of the literature.
Lauridsen JK; Rohde M; Thomassen A
PET Clin; 2015 Jan; 10(1):75-88. PubMed ID: 25455881
[TBL] [Abstract][Full Text] [Related]
11. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
12. Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma.
Andersen KF; Fuglo HM; Rasmussen SH; Petersen MM; Loft A
Medicine (Baltimore); 2015 Dec; 94(51):e2319. PubMed ID: 26705220
[TBL] [Abstract][Full Text] [Related]
13. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
14. Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT.
Varoquaux A; Rager O; Poncet A; Delattre BM; Ratib O; Becker CD; Dulguerov P; Dulguerov N; Zaidi H; Becker M
Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):462-75. PubMed ID: 24108458
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
Kubota K; Yokoyama J; Yamaguchi K; Ono S; Qureshy A; Itoh M; Fukuda H
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):590-5. PubMed ID: 14722678
[TBL] [Abstract][Full Text] [Related]
16. PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient.
Dunsky KA; Wehrmann DJ; Osman MM; Thornberry BM; Varvares MA
Laryngoscope; 2013 Sep; 123(9):2161-4. PubMed ID: 23817791
[TBL] [Abstract][Full Text] [Related]
17. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment tumor SUV
Ha SC; Oh JS; Roh JL; Moon H; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):33-40. PubMed ID: 27448574
[TBL] [Abstract][Full Text] [Related]
20. Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas.
Rakheja R; Makis W; Tulbah R; Skamene S; Holcroft C; Nahal A; Turcotte R; Hickeson M
AJR Am J Roentgenol; 2013 Jul; 201(1):170-7. PubMed ID: 23789672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]